Homepage
Medication Guide
What are the Indications of Lemborexant (Dayvigo)?
Lemborexant (Dayvigo) is a new-type medication for treating insomnia. As an orexin receptor antagonist, it helps improve sleep by regulating the arousal system in the brain.What are the Indications of...
507
Friday, November 21st, 2025, 09:35
What Are the Purchase Channels for Dayvigo (Lemborexant)?
Dayvigo (lemborexant) is a novel orexin receptor antagonist used for the treatment of insomnia, and its access channels and medication safety have attracted significant attention.What Are the Purchase...
506
Thursday, November 20th, 2025, 13:33
How to Purchase Selumetinib (Koselugo)
Selumetinib (Koselugo) is a MEK1/2 kinase inhibitor specifically indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (PN) in pediatric patients aged 1 year and older with ne...
508
Thursday, November 20th, 2025, 13:28
How to Use Selumetinib (Koselugo)
Selumetinib (Koselugo) is a MEK1/2 kinase inhibitor that plays a key role in the treatment of symptomatic, inoperable plexiform neurofibromas (PN) associated with neurofibromatosis type 1 (NF1) in chi...
512
Thursday, November 20th, 2025, 13:07
What is Selumetinib (Koselugo)?
Selumetinib (Koselugo) is a kinase inhibitor primarily used for the treatment of specific types of nervous system tumors. As a targeted therapy drug, its unique pharmacological effects provide an impo...
507
Thursday, November 20th, 2025, 13:04
Side Effects of Ponatinib (Iclusig)
Ponatinib (Iclusig) is a kinase inhibitor that has been approved for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and chronic myeloid leukemia (CML).Side Ef...
511
Thursday, November 20th, 2025, 13:01
Dosage and Administration of Ponatinib (Iclusig)
Ponatinib (Iclusig) is a potent tyrosine kinase inhibitor that plays a crucial role in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and chronic myeloid leuk...
507
Thursday, November 20th, 2025, 11:28
What are the Precautions for Taking Ponatinib (Iclusig)?
Ponatinib (Iclusig) is a potent multi-targeted tyrosine kinase inhibitor primarily indicated for the treatment of patients with chronic phase (CP), accelerated phase (AP), and blast phase (BP) chronic...
508
Thursday, November 20th, 2025, 11:25
What Are the Purchase Channels for Ponatinib (Iclusig)?
Ponatinib (Iclusig) is a new-generation kinase inhibitor that exhibits unique efficacy in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and chronic myeloid l...
519
Thursday, November 20th, 2025, 10:20
What Are the Side Effects of Tukysa (Tucatinib)?
Tukysa (tucatinib) is an oral tyrosine kinase inhibitor primarily used for the treatment of HER2-positive advanced or metastatic breast cancer and colorectal cancer. While it demonstrates significant ...
510
Thursday, November 20th, 2025, 10:13
57 / 214
2139 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved